The synthesis, antimicrobial activity and docking studies of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-ones with acetamide and 1,2,4-oxadiazol-5-ylmethyl substituents
Aim. To synthesize, study the antimicrobial activity and suggest antimicrobial activity mechanism for the novel derivatives of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-one. Results and discussion. As the result of the targeted modification of 6-(1H-benzimidazol-2-yl)-5-methylth...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN RU UK |
| Publicado: |
National University of Pharmacy (Kharkiv, Ukraine)
2021
|
| Materias: | |
| Acceso en línea: | https://doi.org/10.24959/ophcj.21.240775 https://doaj.org/article/c248549c64f247df8e09fe7bbe25133d |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:c248549c64f247df8e09fe7bbe25133d |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:c248549c64f247df8e09fe7bbe25133d2021-11-14T22:08:40ZThe synthesis, antimicrobial activity and docking studies of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-ones with acetamide and 1,2,4-oxadiazol-5-ylmethyl substituentshttps://doi.org/10.24959/ophcj.21.2407752308-83032518-1548https://doaj.org/article/c248549c64f247df8e09fe7bbe25133d2021-09-01T00:00:00Zhttp://ophcj.nuph.edu.ua/article/view/240775https://doaj.org/toc/2308-8303https://doaj.org/toc/2518-1548Aim. To synthesize, study the antimicrobial activity and suggest antimicrobial activity mechanism for the novel derivatives of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-one. Results and discussion. As the result of the targeted modification of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]-pyrimidin-4(3H)-one in position 3 with acetamide and 1,2,4-oxadiazol-5-ylmethyl substituents, the compounds, which demonstrated better antimicrobial activity in the agar well diffusion assay than the reference drug Streptomycin, were obtained. To elucidate the mechanism of action of the novel compounds, the docking studies were conducted to the active site of the 16S subunit of ribosomal RNA, the proven target for aminoglycoside antibiotics, as well as tRNA (Guanine37-N1)-methyltransferase (TrmD), which inhibitors were considered as a new potential class of antibiotics. Experimental part. By the interaction of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-one with a series of N-arylchloroacetamides and 3-aryl-5-(chloromethyl)-1,2,4-oxadiazoles in DMF in the presence of K2CO3 the target compounds were obtained. The antimicrobial activity was assessed by the agar well diffusion method. The concentration of microbial cells was determined by the McFarland standard; the value was 10^7 cells in 1 mL of the media. The 18–24 hour culture of microorganisms was used for tests. For the bacteria cultivation, Müller-Hinton agar was used, Sabouraud agar was applied for C. albicans cultivation. The compounds were tested as the DMSO solution with the concentration of 100 µg/mL; the volume of the solution was 0.3 mL, the same volume was used for Streptomycin (the concentration 30 µg/mL). The docking studies were performed using Autodock Vina. Crystallographic data for the complexes of Streptomycin with the 16S subunit of ribosomal RNA (1NTB) and its active site, as well as for tRNA (Guanine37-N1)-methyltransferase (EC 2.1.1.228; TrmD) (5ZHN) and its active site were obtained from the Protein Data Bank. Conclusions. It has been determined that 2-[6-(1H-benzimidazol-2-yl)-5-methyl-4-oxothieno[2,3-d]pyrimidin-3(4H)-yl]-N-[4-(ethoxy)phenyl]acetamide, which is the most active as an antimicrobial agent among the compounds tested, also shows the best binding activity towards the active site of tRNA (guanine37-N1)-methyltransferase. Sergiy V. VlasovOleksandr V. BorysovHanna I. SeverinaSergiy M. KovalenkoTetiana P. OsolodchenkoVitaliy S. VlasovVictoriya A. GeorgiyantsNational University of Pharmacy (Kharkiv, Ukraine)articlethiophenepyrimidinealkylationantimicrobial agentsinhibitorsmolecular dockingChemistryQD1-999ENRUUKЖурнал органічної та фармацевтичної хімії, Vol 19, Iss 3, Pp 15-20 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN RU UK |
| topic |
thiophene pyrimidine alkylation antimicrobial agents inhibitors molecular docking Chemistry QD1-999 |
| spellingShingle |
thiophene pyrimidine alkylation antimicrobial agents inhibitors molecular docking Chemistry QD1-999 Sergiy V. Vlasov Oleksandr V. Borysov Hanna I. Severina Sergiy M. Kovalenko Tetiana P. Osolodchenko Vitaliy S. Vlasov Victoriya A. Georgiyants The synthesis, antimicrobial activity and docking studies of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-ones with acetamide and 1,2,4-oxadiazol-5-ylmethyl substituents |
| description |
Aim. To synthesize, study the antimicrobial activity and suggest antimicrobial activity mechanism for the novel derivatives of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-one.
Results and discussion. As the result of the targeted modification of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]-pyrimidin-4(3H)-one in position 3 with acetamide and 1,2,4-oxadiazol-5-ylmethyl substituents, the compounds, which demonstrated better antimicrobial activity in the agar well diffusion assay than the reference drug Streptomycin, were obtained. To elucidate the mechanism of action of the novel compounds, the docking studies were conducted to the active site of the 16S subunit of ribosomal RNA, the proven target for aminoglycoside antibiotics, as well as tRNA (Guanine37-N1)-methyltransferase (TrmD), which inhibitors were considered as a new potential class of antibiotics.
Experimental part. By the interaction of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-one with a series of N-arylchloroacetamides and 3-aryl-5-(chloromethyl)-1,2,4-oxadiazoles in DMF in the presence of K2CO3 the target compounds were obtained. The antimicrobial activity was assessed by the agar well diffusion method. The concentration of microbial cells was determined by the McFarland standard; the value was 10^7 cells in 1 mL of the media. The 18–24 hour culture of microorganisms was used for tests. For the bacteria cultivation, Müller-Hinton agar was used, Sabouraud agar was applied for C. albicans cultivation. The compounds were tested as the DMSO solution with the concentration of 100 µg/mL; the volume of the solution was 0.3 mL, the same volume was used for Streptomycin (the concentration 30 µg/mL). The docking studies were performed using Autodock Vina. Crystallographic data for the complexes of Streptomycin with the 16S subunit of ribosomal RNA (1NTB) and its active site, as well as for tRNA (Guanine37-N1)-methyltransferase (EC 2.1.1.228; TrmD) (5ZHN) and its active site were obtained from the Protein Data Bank.
Conclusions. It has been determined that 2-[6-(1H-benzimidazol-2-yl)-5-methyl-4-oxothieno[2,3-d]pyrimidin-3(4H)-yl]-N-[4-(ethoxy)phenyl]acetamide, which is the most active as an antimicrobial agent among the compounds tested, also shows the best binding activity towards the active site of tRNA (guanine37-N1)-methyltransferase. |
| format |
article |
| author |
Sergiy V. Vlasov Oleksandr V. Borysov Hanna I. Severina Sergiy M. Kovalenko Tetiana P. Osolodchenko Vitaliy S. Vlasov Victoriya A. Georgiyants |
| author_facet |
Sergiy V. Vlasov Oleksandr V. Borysov Hanna I. Severina Sergiy M. Kovalenko Tetiana P. Osolodchenko Vitaliy S. Vlasov Victoriya A. Georgiyants |
| author_sort |
Sergiy V. Vlasov |
| title |
The synthesis, antimicrobial activity and docking studies of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-ones with acetamide and 1,2,4-oxadiazol-5-ylmethyl substituents |
| title_short |
The synthesis, antimicrobial activity and docking studies of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-ones with acetamide and 1,2,4-oxadiazol-5-ylmethyl substituents |
| title_full |
The synthesis, antimicrobial activity and docking studies of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-ones with acetamide and 1,2,4-oxadiazol-5-ylmethyl substituents |
| title_fullStr |
The synthesis, antimicrobial activity and docking studies of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-ones with acetamide and 1,2,4-oxadiazol-5-ylmethyl substituents |
| title_full_unstemmed |
The synthesis, antimicrobial activity and docking studies of 6-(1H-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3H)-ones with acetamide and 1,2,4-oxadiazol-5-ylmethyl substituents |
| title_sort |
synthesis, antimicrobial activity and docking studies of 6-(1h-benzimidazol-2-yl)-5-methylthieno[2,3-d]pyrimidin-4(3h)-ones with acetamide and 1,2,4-oxadiazol-5-ylmethyl substituents |
| publisher |
National University of Pharmacy (Kharkiv, Ukraine) |
| publishDate |
2021 |
| url |
https://doi.org/10.24959/ophcj.21.240775 https://doaj.org/article/c248549c64f247df8e09fe7bbe25133d |
| work_keys_str_mv |
AT sergiyvvlasov thesynthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT oleksandrvborysov thesynthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT hannaiseverina thesynthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT sergiymkovalenko thesynthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT tetianaposolodchenko thesynthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT vitaliysvlasov thesynthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT victoriyaageorgiyants thesynthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT sergiyvvlasov synthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT oleksandrvborysov synthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT hannaiseverina synthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT sergiymkovalenko synthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT tetianaposolodchenko synthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT vitaliysvlasov synthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents AT victoriyaageorgiyants synthesisantimicrobialactivityanddockingstudiesof61hbenzimidazol2yl5methylthieno23dpyrimidin43honeswithacetamideand124oxadiazol5ylmethylsubstituents |
| _version_ |
1718429008560914432 |